Poly(ADP-ribose) polymerase inhibitors as promising cancer therapeutics

The year of 2005 was a watershed in the history of poly(ADP-ribose) polymerase (PARP) inhibitors due to the important findings of selective killing in BRCA-deficient cancers by PARP inhibition. The findings made PARP inhibition one of the most promising new therapeutic approaches to cancers, especia...

Full description

Saved in:
Bibliographic Details
Main Authors: He, Jin-xue, Yang, Chun-hao, Miao, Ze-hong
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 2010
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4002295/
https://ncbi.nlm.nih.gov/pubmed/20676117
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/aps.2010.103
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items